Core Insights - Reinsurance Group of America, Incorporated (RGA) is a global leader in the reinsurance industry, providing life and health-related reinsurance solutions and competing with major firms to maintain its market position through strategic growth and innovation [1] Financial Performance - Piper Sandler set a new price target of $263 for RGA, indicating a potential 15.5% increase from the current stock price of $227.70, reflecting confidence in RGA's future performance [2][6] - RGA's stock price recently showed a 10.20% increase, or $21, indicating positive market sentiment [2][6] - The company's Q4 2025 earnings call provided insights into financial health, revenue growth, and strategic plans, with discussions from C-suite executives on future outlook and market conditions [3][6] Market Activity - RGA's stock has shown volatility, with prices fluctuating between a low of $218.58 and a high of $229.17 on a recent trading day, and over the past year, the stock reached a high of $229.21 and a low of $159.25 [4] - The company's market capitalization is approximately $14.92 billion, with a trading volume of 662,902 shares on the NYSE [4] Strategic Focus - RGA's performance and market position are closely monitored by investors and analysts, with the company's ability to navigate market conditions and capitalize on growth opportunities being crucial for achieving the new price target set by Piper Sandler [5]

Financial Data and Key Metrics Changes - The company reported Q4 operating EPS of $7.75 per share, marking the second consecutive record quarter in earnings [6] - Adjusted operating return on equity (ROE) for the trailing 12 months was 15.7%, exceeding the intermediate-term target range of 13%-15% [6][18] - For the full year 2025, the company achieved record operating EPS and increased the value of in-force business margins by 18% [6][13] Business Line Data and Key Metrics Changes - In the U.S., favorable results were driven by management actions and variable investment income, with individual life mortality in line with expectations [7] - EMEA results showed strong volume growth and favorable experience, with full-year pre-tax earnings up 35% [11] - APAC region reported an 18% increase in pre-tax operating income, reflecting strong underlying growth and favorable underwriting experience [10] Market Data and Key Metrics Changes - Premium growth was 7.4% year-to-date on a constant currency basis, benefiting from strong growth across North America, EMEA, and APAC [19] - The U.S. healthcare business has approximately $400 million of annual premium, generating about $25 million of pre-tax run rate earnings in a typical year [43] Company Strategy and Development Direction - The company plans to exit the group healthcare lines of business after 2026, focusing on strategically aligned businesses [12][43] - The strategy includes optimizing the balance sheet, enhancing risk-adjusted investment returns, and maintaining a focus on capital stewardship [15][16] - The company aims for a balanced approach to capital deployment, targeting a total payout ratio of 20%-30% for buybacks and dividends [37][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to meet or exceed intermediate-term financial targets, citing strong momentum and a clear focus on strategy [16][33] - The company anticipates a more limited financial impact from in-force management actions in 2026 compared to recent years [24][91] - Management noted that higher interest rates are beneficial for overall earnings, given positive reinvestment cash flows [95] Other Important Information - The company deployed $2.5 billion of capital into in-force transactions for the full year, with $98 million in Q4 [19][20] - The effective tax rate for Q4 was 23.8%, with an expectation of 22%-23% for 2026 [20] - The company reported an estimated excess capital of $2.7 billion at the end of the quarter [30] Q&A Session Summary Question: Capital allocation and payout ratio - Management confirmed the target of a 20%-30% total payout ratio while maintaining flexibility for capital deployment [37] Question: Group health rate actions and business exit - Significant rate actions were taken, including a 40% average increase, and the decision to exit the group healthcare business was driven by strategic alignment [42][43] Question: Equitable block performance - The Equitable transaction is expected to generate $160 million-$170 million of earnings in 2026, with various factors contributing to economic upside [49] Question: Long-term care risk transfer deal performance - Management expressed satisfaction with the long-term care business performance, aligning with risk appetite and return expectations [62] Question: Investment portfolio exposure to software-related companies - The company has modest exposure to software lending, and AI impacts are actively monitored across the portfolio [67][68] Question: Regulatory changes in Europe and competition - Management noted no significant competitive threats arising from regulatory changes in Europe, focusing on opportunities with both asset and biometric risks [76][78] Question: Attractive regions or product lines for 2026 - The company highlighted a strong pipeline in Asia and the U.K. longevity market, with optimism about delivering attractive returns [81]

Financial Data and Key Metrics Changes - The company reported Q4 operating EPS of $7.75 per share, marking the second consecutive record quarter in earnings [6] - Adjusted operating return on equity (ROE) for the trailing 12 months was 15.7%, exceeding the intermediate-term target range of 13%-15% [6][17] - For the full year 2025, the company achieved record operating EPS and increased the value of Inforce business margins by 18% [6][10] Business Line Data and Key Metrics Changes - The U.S. market showed favorable results driven by management actions and variable investment income, with individual life mortality in line with expectations [8] - EMEA results reflected strong volume growth and favorable experience, with full-year pre-tax earnings up 35% [11] - APAC continued to see growth momentum, with pre-tax operating income up 18% for the year [10][11] Market Data and Key Metrics Changes - Premium growth was 7.4% year-to-date on a constant currency basis, benefiting from strong growth across North America, EMEA, and APAC [18] - The U.S. healthcare business has approximately $400 million of annual premium, generating about $25 million of pre-tax run rate earnings [39] Company Strategy and Development Direction - The company is focused on a proactive business approach, optimizing its balance sheet, operational scaling, and capital stewardship to generate long-term shareholder value [14][15] - A strategic review led to the decision to exit the group healthcare lines of business, with a focus on deploying capital in strategically aligned businesses [12][39] - The company aims to maintain a balanced approach to capital deployment, targeting a total payout ratio of 20%-30% for buybacks and dividends [32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to generate attractive shareholder value going forward, supported by a strong pipeline of opportunities across various regions [16][77] - The company anticipates a more limited financial impact from Inforce management actions in 2026 compared to recent years [22][83] - Higher interest rates are viewed positively for overall earnings, with modest exposure to disintermediation risk from higher rates [89] Other Important Information - The company successfully repurchased $50 million of shares in Q4, totaling $125 million since reinstating buybacks [10][18] - The effective tax rate for Q4 was 23.8%, with expectations for 2026 in the range of 22%-23% [18] Q&A Session Summary Question: Capital allocation and payout ratio - Management confirmed the target of a 20%-30% total payout ratio while maintaining flexibility for capital deployment [32] Question: Group health rate actions and exit strategy - Significant rate actions were taken, including a 40% average increase, and the decision to exit the group healthcare business was driven by strategic alignment [38][39] Question: Performance of the Equitable block - The Equitable transaction is expected to generate earnings of $160-$170 million in 2026, with various drivers of economic upside identified [45][46] Question: Long-term care risk transfer deal performance - Management expressed satisfaction with the long-term care business performance, aligning with risk appetite and return expectations [57] Question: Exposure to software-related companies and AI disruption - The company has modest exposure to software lending and actively assesses the impact of AI on the investment portfolio [62] Question: Regulatory changes in Europe and competition - Management noted no significant competitive threats arising from regulatory changes in Europe, focusing on opportunities with both asset and biometric risks [72][73]

Financial Data and Key Metrics Changes - The company reported Q4 operating EPS of $7.75 per share, marking the second consecutive record quarter in earnings [4] - Adjusted operating return on equity (ROE) for the trailing 12 months was 15.7%, exceeding the intermediate-term target range of 13%-15% [4][14] - Full year 2025 results included record operating EPS and a 15.7% ROE, with Inforce business margins increasing by 18% [4][5] Business Line Data and Key Metrics Changes - The U.S. region showed favorable results driven by management actions and variable investment income, with individual life mortality in line with expectations [5] - EMEA results reflected strong volume growth and favorable experience, while APAC continued to see growth momentum [5][9] - The Equitable block contributed positively, with earnings consistent with guidance for the second half of 2025 and expected earnings of $160-$170 million in 2026 [21][34] Market Data and Key Metrics Changes - Premium growth was 7.4% year-to-date on a constant currency basis, benefiting from strong growth across North America, EMEA, and APAC [16] - The APAC region produced excellent bottom-line results for the year, with pre-tax operating income up 18% [8][9] - EMEA's full year pre-tax earnings were up 35%, reflecting strong new business growth [9] Company Strategy and Development Direction - The company is focused on four key areas: proactive business approach, balance sheet optimization, operational scaling, and capital stewardship [12] - A strategic review led to the decision to exit the group healthcare lines of business, with significant rate increases implemented [10][31] - The company aims to maintain a balanced approach to capital deployment while returning capital to shareholders [28][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to generate attractive shareholder value going forward, supported by a strong pipeline of opportunities [13][48] - The company anticipates a more limited financial impact from Inforce management actions in 2026 compared to recent years [20][52] - The expected tax rate for 2026 is projected to be in the range of 22%-23% [16] Other Important Information - The company ended the quarter with estimated excess capital of $2.7 billion and deployable capital of $3.4 billion for the next 12 months [16][24] - The non-spread book yield was slightly higher than Q3, driven by new money rates exceeding portfolio yields [24] Q&A Session Summary Question: Capital allocation and payout ratio - Management confirmed the target of a 20%-30% payout ratio remains appropriate, balancing capital deployment with shareholder returns [27][28] Question: Group health rate actions and business exit - Significant rate increases of 40% were implemented, and the decision to exit the group healthcare business was driven by strategic alignment [30][31] Question: Long-term care risk transfer deal performance - Management expressed satisfaction with the long-term care business performance, aligning with risk appetite and return expectations [39] Question: Exposure to software-related companies and AI disruption - The company has minimal exposure to software lending and is actively managing the portfolio in light of AI trends [41] Question: Regulatory changes in Europe and competition - Management noted no significant competitive threats arising from regulatory changes, focusing on opportunities with both asset and biometric risks [44][46] Question: Opportunities in specific regions or product lines - The company highlighted strong pipelines in Asia and the UK longevity market, with optimism about future returns [47][48]

4Q25 Earnings Presentation Reinsurance Group of America, Incorporated 02.05.2026 1 Safe Harbor This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and federal securities laws including, among others, statements relating to projections of the future operations, strategies, earnings, revenues, income or loss, ratios, financial performance, and growth potential of Reinsurance Group of America, Incorporated (the "Company"). Forward-looking ...

Reinsurance Group of America, Incorporated (RGA) has disclosed full year 2025 net income available to its shareholders of $1.182 billion, up from $717 million in 2024.Adjusted operating income was also up for the full year 2025, reaching $1.518 billion, compared with $1.342 billion in 2024.Meanwhile, RGA’s net premiums in 2025 totalled $17.2 billion, a decrease of 3.4% from 2024, with a favourable net foreign currency effect of $56 million.According to the firm, net premiums for the full year included a con ...

Core Insights - Reinsurance Group (RGA) reported a revenue of $6.77 billion for Q4 2025, marking a year-over-year increase of 23.4% and exceeding the Zacks Consensus Estimate of $6.11 billion by 10.86% [1] - The company's EPS for the same quarter was $7.75, up from $4.99 a year ago, representing an EPS surprise of 32.16% against the consensus estimate of $5.86 [1] Financial Performance Metrics - Net premiums from U.S. and Latin America Financial Solutions reached $443 million, surpassing the average estimate of $218.7 million [4] - Net premiums from EMEA Financial Solutions were reported at $263 million, exceeding the average estimate of $217.71 million [4] - Other revenues from Asia Pacific Financial Solutions totaled $12 million, compared to the average estimate of $5.62 million [4] - Other revenues from Asia Pacific Traditional were $7 million, exceeding the average estimate of $3.67 million [4] - Other revenues from Canada Financial Solutions were $1 million, below the average estimate of $4.56 million [4] - Other revenues from Corporate and Other were $29 million, surpassing the average estimate of $18.92 million [4] - Other revenues from EMEA Financial Solutions were $14 million, slightly above the average estimate of $13.28 million [4] - Net investment income from Asia Pacific Financial Solutions was $288 million, exceeding the average estimate of $252.94 million [4] - Net investment income from Asia Pacific Traditional was $76 million, slightly above the average estimate of $74.41 million [4] - Total net investment income was reported at $1.69 billion, exceeding the average estimate of $1.49 billion and reflecting a year-over-year increase of 42.7% [4] - Total revenues from net premiums were $4.78 billion, surpassing the average estimate of $4.37 billion, with a year-over-year increase of 15% [4] - Total other revenues were $299 million, slightly below the average estimate of $322.79 million, but showing a significant year-over-year change of 103.4% [4] Stock Performance - Shares of Reinsurance Group have returned +2% over the past month, outperforming the Zacks S&P 500 composite's +0.5% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Investor Presentation Fourth Quarter 2025 Cautionary Note On Forward-Looking Statements and Non-GAAP Measures This presentation and the accompanying remarks contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. federal securities laws. These statements reflect management's current expectations based on assumptions we b ...

Core Viewpoint - Reinsurance Group of America (RGA) is a leading global provider in the life and health reinsurance sector, with a positive outlook reflected in the increasing consensus price target from analysts [1][2][6] Price Target Trends - The average price target for RGA has risen from $219.63 a year ago to $237.50 last month, indicating a significant increase of $17.87 over the year and $9.25 over the last quarter [2][4][3] - Wells Fargo has set a price target of $238 for RGA, aligning with the positive sentiment from analysts regarding the stock's potential upside [2][6] Analyst Sentiment - Analysts have shown growing confidence in RGA's performance, as evidenced by the increase in the average price target and the positive Zacks Rank system, which highlights RGA as a promising stock despite some limitations [3][4] - The consensus price target increase reflects a strong upward trend in analyst expectations, suggesting optimism about RGA's growth potential [4][6] Earnings Expectations - RGA is expected to experience earnings growth, although it may not achieve an earnings beat in the upcoming fourth-quarter report scheduled for February 5 [5]

Oxbridge Re Holdings Conference Summary Company Overview - **Company Name**: Oxbridge Re Holdings - **Ticker Symbol**: OXBR - **Industry**: Reinsurance - **Location**: Cayman Islands - **Business Model**: Oxbridge operates as a reinsurance underwriter, focusing on homeowners insurance and utilizing blockchain technology to democratize access to reinsurance contracts through its subsidiary, SurancePlus [6][7][8][21]. Key Points and Arguments Business Model and Strategy - Oxbridge has transitioned traditional reinsurance into the blockchain space, allowing broader access to investment opportunities that typically require significant capital [7][8][15]. - The company offers tokenized securities that enable individuals to invest in reinsurance contracts with as little as $5,000, significantly lowering the barrier to entry [9][18][19]. - SurancePlus, the subsidiary, facilitates this democratization by managing the investment process and ensuring compliance with AML and KYC regulations [21][22]. Market Opportunity - The reinsurance market is valued at approximately $700 billion, with a significant opportunity for growth as many individuals are unaware of reinsurance and its benefits [14][24]. - Florida is identified as a key market due to its high frequency of hurricanes and the associated reinsurance costs, with $0.45 of every $1 in insurance premiums going towards reinsurance [28][30]. Performance Metrics - In 2023, Oxbridge targeted a 42% return on investments through its token offerings, achieving a 49% payout [13][18]. - The company reported that its 20% targeted return is currently tracking at about 25% [18]. Risk Management - Oxbridge employs a fully collateralized structure for its reinsurance contracts, meaning that it must back its contracts with cash, reducing counterparty risk and enhancing trust with investors [31][32]. - The company focuses on writing contracts primarily in Florida, leveraging its expertise in the region to manage risk effectively [26][28]. Future Growth and Milestones - Oxbridge plans to expand its SurancePlus platform and is exploring the potential to spin it off as a separate publicly traded entity [37][38]. - The company is moving its operations to the Solana blockchain to enhance growth opportunities and attract more investors [19][22]. Upcoming Announcements - Oxbridge is expected to make announcements regarding the growth of Assurance Plus and potential new strategies, including possible AI integrations [39][40]. Additional Important Information - The company emphasizes the importance of clarity, security, and compliance in its operations, which are critical for attracting investors [24][25]. - Oxbridge's approach to reinsurance is characterized by a focus on high-quality underwriting and risk dispersion, ensuring that the risks taken are well-managed [34][36]. This summary encapsulates the key insights from the Oxbridge Re Holdings conference, highlighting the company's innovative approach to reinsurance, market opportunities, and strategic growth plans.